Report
The Role of MYCN in the Failure of MYCN Amplified Neuroblastoma Cell Lines to G 1 Arrest After DNA Damage
ABsTRACT
We previously reported that 3 p53 wild type (wt) MYCN amplified (MNA) neuroblastoma cell lines failed to G 1 arrest after DNA damage despite induction of p53, p21 WAF1 and MDM2. We hypothesised that this was due to high MYCN expression. p53 responses to DNA damage were examined in an additional 13 p53 wt neuroblastoma cell lines. MNA was significantly associated with a failure to G 1 arrest after DNA damage (p < 0.001) and higher levels of apoptosis after irradiation (p < 0.05). p21 WAF1 and hypophosphorylated (hypo) RB accumulation post irradiation were significantly lower in cell lines that failed to G 1 arrest (p < 0.05). Conditional MYCN expression in non-MNA SHEP Tet21N cells did not affect the G 1 arrest after irradiation. MYCN knockdown using siRNA in 3 p53 wt MNA cell lines did not restore a G 1 arrest after irradiation, but increased the baseline G 1 population, p21 WAF1 and hypo RB expression. MYCN siRNA also caused a G 1 arrest in a p53 mutant MNA cell line. This study is the first to determine that MNA correlates with a failure to G 1 arrest and attenuated p21 WAF1 induction; however MYCN expression alone is not causally responsible.
InTRoDUCTIon
The MYCN oncogene is amplified in 25% of neuroblastoma and is strongly associated with a poor prognosis. 1 MYCN is located on chromosome 2p24 and encodes a 60-63 kDa transcription factor that is a member of the MYC family. MYC transcription factors have a conserved structure which includes a transcriptional activation domain in the N-terminus and a C-terminus basic helix-loop-helix/leucine zipper domain that plays a role in protein dimerisation, sequence specific DNA binding and the regulation of transcription. 2 MYCN heterodimerises with MAX and binds to E-box DNA sequences in promoters of MYCN target genes. MYCN expression is limited to central and peripheral nervous systems, kidney, lungs and spleen during embryonic development, unlike its counterpart MYC that is expressed in multiple tissues at all stages of development. 3 A number of studies have characterised the role of MYCN in tumor progression and tumorigenicity. A transgenic mouse model, in which high levels of MYCN were expressed in neuroectodermal cells, developed neuroblastoma with chromosomal losses and gains in regions orthologous to those found in human neuroblastoma. 4, 5 Reduction of MYCN expression using MYCN antisense oligonucleotides in the same model decreased proliferation and induced neuronal differentiation of neuroblastoma cells. 6 Conditional expression of MYCN in a non-MNA neuroblastoma cell line has been shown to shorten the time taken to progress through the cell cycle, increase proliferation and decrease attachment of cells to the extra-cellular matrix. 7 Although MNA is a poor prognostic indicator, the clinical role of MYCN expression has not been as clearly defined. A recent report has suggested that high levels of MYCN expression in tumors lacking amplification is associated with a favorable prognosis, and induced expression of MYCN in p53 mutant SK-N-AS cells slows growth by increasing levels of apoptosis and increasing the expression of favorable genes. 8 p53 has been described as 'the guardian of the genome'. 9 After DNA damage, p53 binds DNA in a sequence specific manner and activates the transcription of a number of genes including MDM2, BAX and p21 WAF1 . MDM2 forms an auto-regulatory feedback loop with p53. The induction of p21 WAF1 , a cyclin-dependent kinase inhibitor, induces a G 1 arrest until DNA has been repaired or apoptosis has been initiated. 10 p53 has been described as the most frequently mutated gene in human cancer and is particularly prevalent in adult malignancies; however several studies have found that p53 mutations in both neuroblastoma tumors and cell lines are rare. 11, 12 When p53 mutations do occur they are in progressive and relapsed neuroblastoma, suggesting that p53 mutations occur as a mechanism for resistance to cytotoxic drugs that target the p53 pathway. 11 Other aberrations in the p53 pathway have been described to occur at relapse, such as MDM2 amplification, and p14 ARF deletion and methylation. 13 MDM2 has been shown to be a direct transcriptional target of MYCN, with MYCN binding to the E-box in the P2 promoter region of MDM2. Slack et al propose that MYCN expression decreases the stability of p53 through increasing levels of MDM2 expression, consequently inhibiting MYCN driven apoptosis. 14 An attenuated G 1 arrest in response to DNA damage has been observed in some wt p53 neuroblastoma cell lines despite induction of p53, MDM2 and p21 WAF1 . [15] [16] [17] [18] It has previously been reported that the MNA, p53 wt cell lines SK-N-BE(1n), IMR-32 and NGP all fail to undergo a G 1 arrest in response to DNA damage and the non-MNA cell lines SHEP, SKNSH and SH-SY-5Y all undergo a G 1 arrest post irradiation. 17, 18 This suggests that a failure to G 1 arrest is linked to MNA. In this study, the p53 responses to DNA damage were investigated in a further seven MNA and six non-MNA p53 wt cell lines to extend the above observations. To test the hypothesis that high MYCN expression is causally linked to a failure to undergo a G 1 arrest in response to DNA damage, MYCN expression was manipulated in the non-MNA SHEP cell line with a tetracycline regulated Tet21N MYCN expression vector. In addition MYCN was knocked down using siRNA in four MNA cell lines to determine if reduction of MYCN would restore a G 1 arrest in response to DNA damage.
mATERIALs AnD mEThoDs
Tissue culture. Seventeen p53 wt human Mycoplasma-free neuroblastoma cell lines were studied. 13 The non-MNA cell lines were: SJNB-1, 19 NBL-S, 20 18 and NBLW. 30 The MNA p53 mutant cell line SKNBE(2c) with a missense mutation in exon 5 codon 135: TGC (cysteine) to TTC (phenylalanine) 18 was used for siRNA experiments. All cell lines were grown in RPMI 1640 (Gibco, Paisley, UK) supplemented with 10% FCS (Gibco). Cells were grown at 37˚C, in a humidified incubator with 5% CO 2 .
DNA damage by g-irradiation. Cells were plated in 28 cm 2 tissue culture dishes (Nunc, Naperville, IL) at 5 x 10 5 cells per plate and irradiated when ~70% confluent with 4 Gy 310 kV X-rays from a RS320 irradiation system (Gulmay Medical, Surrey, UK). Cells were harvested 2, 6 and 24 hors post irradiation for Western blotting and 24 hours post irradiation for cell cycle analysis. Experiments were carried out at least n = 2.
Protein lysate preparation and Western blotting. Whole cell extracts were prepared, and 30 mg protein/sample separated by gel electrophoresis and Western blotting performed using methods previously described. 17 Densitometry was performed using a Fuji-Las camera and the AIDA image analyser program (Raytek, Sheffield, UK) used to quantify band intensities.
Antibodies. Primary antibodies used were mouse monoclonal p53 DO7 at 1:1000 dilution (Novocastra, Newcastle, UK), MDM2 at 1:100, p21 WAF1 at 1:100 (Calbiochem, Cambridge, MA), hypophosphorylated retinoblastoma protein (Hypo RB) at 1:100 and total retinoblastoma protein at 1:500, both from BD biosciences (Oxford UK) and the mouse monoclonal MYCN 100 antibody at 1:10 (gift from N. Igekaki). b-actin rabbit polyclonal used as a protein loading and transfer control at 1:1000 (Sigma, St Louis, MO). The secondary goat anti-mouse IgG and goat-anti rabbit IgG antibodies were both HRP conjugated and used at 1:1000 (DAKO, Glostrup, Denmark). SHEP Tet21N MYCN expression system. The SHEP Tet21N cell line 7 was grown in RPMI 1640 supplemented with 10% tetracycline-free FCS (Clontech, Mountain View, CA) G418 and Hygromycin (Promega, Southampton, UK). SHEP Tet21N cells express MYCN in the absence of tetracycline. To switch off MYCN expression, 10 ng/ml Tetracycline (Sigma) was added to the growth media at least 24 hours prior to experiments.
Flow cytometry. Adherent cells (~2 x 10 6 ) were harvested with trypsin 24 hours post irradiation, fixed in ice cold 70% Ethanol 30% PBS solution and stored at 4˚C. Cells were resuspended in fresh PBS with 40 mg/ml propidium iodide and 0.1 mg/ml RNAse A (Sigma) and incubated at 37˚C for 30 minutes. Measurements were performed using a FACScan (Becton Dickinson Oxford, UK) and analysed using Cell Quest software (Beckton Dickinson) and WinMDI software (TSRI, La Jolla, USA). Cell cycle experiments were performed in triplicate.
Apoptosis measurements. Apoptosis measurements using Hoechst and FACs were carried out as described previously. 17 Cells were harvested 24, 48, 72 and 96 hours post irradiation, and apoptosis experiments for both methods were carried out in triplicate.
MYCN expression measured by quantitative reverse transcriptase PCR. RNA extraction, reverse transcriptase PCR and real time PCR was carried out as described in Carr et al. 13 Primers and probes for both the MYCN and the b-Actin control were Taqman assays from Applied Biosystems (Foster City, CA). Each of the samples were run in triplicate on a 384 well plate using a ABI prism 7900 detection kit (Applied Biosystems). Each experiment was carried out in triplicate. RNA Interference of MYCN. Small interfering RNA (siRNA) oligonucleotides targeted against exon 2 of MYCN were synthesised by Eurogentec (Seraing, Belgium). The sense strand of the MYCN siRNA sequence was: UGAUCUGCAAGAACCCAGA. A scrambled sequence of the MYCN siRNA was used as a negative control. The scrambled (SCR) control sequence was: AUGUUAUCUGGCCCGUGUA. A BLAST ™ database search was carried out against the human genome (nucleotide database) to ensure that MYCN and SCR sequences had no cross reactivity with other gene transcripts. MYCN siRNA was transiently transfected into cells at final concentrations of either 25 nM for NGP and SKNBE(2c) or 40 nM for IMR-32 and NBLW using Lipofectamine (Invitrogen, Paisley, UK) for 24 hours according to manufacturer's instructions. Knock down of MYCN using siRNA was monitored by Western blot analysis and performed in 4 MNA neuroblastoma cell lines: p53 wt IMR-32, NBLW, NGP and the p53 mutant cell line SK-N-BE(2c). The results for FACs cell cycle and Western blot densitometry displayed in the figures were for the concentration of siRNA that gave the most consistent cell cycle results and percentage MYCN knockdown. Optimal MYCN knockdown was at 16 hours and was measured 48 hours later before an increase in MYCN returned.
Statistics. For statistical tests, some data sets did not have a normal distribution, (determined using an Anderson Darling Normality test) so a Mann Whitney test was used throughout with the level of statistical significance taken as p < 0.05. REsULTs p53 transcriptional function in response to DNA damage. The p53 functional response to DNA damage was investigated using Western blotting for p53, MDM2, p21 WAF1 and hypo RB in 17 p53 wt neuroblastoma cell lines, 7 non-MNA and 10 MNA cell lines (Table 1 and Fig. 1 ). Each sample was compared to a positive control (the 6 hours post irradiation SKNRA sample). The non-MNA SKNRA cell line has previously been reported to have an intact p53 response to DNA damage. 12 The non-MNA cell lines: GIMEN, SJNB-1, SKNRA, LAN-6, NBL-S, SHSY5Y all had higher levels of p21 WAF1 induction after DNA damage compared with MNA cell lines (Fig. 1A and B) . The NB69 non-MNA cell line had relatively low levels of p21 WAF1 and hypo RB after irradiation ( Fig. 1 and Table 1 ). Lower levels of p21 WAF1 and hypo RB induction were observed in 9/10 MNA cell lines: SMSKCNR, CHLA-136, IMR-32, NBLW, NGP, TR14, LS, SKNBE1n and CHP902R ( Fig. 1 and Table 1 ). The MNA PER-108 cell line had higher levels of p21 WAF1 and hypo RB induction compared with other MNA cell lines, similar to levels in non-MNA cell lines (Fig. 1) . Levels of p21 WAF1 induction 6 and 24 hours post irradiation were significantly lower in MNA compared with non-MNA cell lines (p < 0.01 and p < 0.05) (Fig. 1B) and levels of hypo RB were significantly lower 6 and 24 hours post irradiation (p < 0.01).
Comparison of induced p53 and MDM2 levels showed no significant difference between MNA and non-MNA cell lines (Table 1) .
Cell cycle arrest after irradiation of cell lines. The SKNRA cell line shown in Figure 2A as an example of a non-MNA cell line, underwent a significant G 1 arrest 24 hours after irradiation (p < 0.001). The proportion of cells in G 1 increased from 78.4 ± 1.2% to 88.0 ± 1.4% and the proportion in S-phase decreased from 9.8 ± 0.5% to 1.6 ± 0.1%. The G 1 :S ratio increased from 8.3 ± 0.5 to 60.8 ± 8.7 post irradiation ( Fig. 2A and C) . All six non-MNA cell lines underwent a G 1 arrest in response to DNA damage ( Fig. 2A and C) . Cell cycle data for the non-MNA NBL-S cell line is consistent with a previous report showing a significant G 1 arrest after irradiation in this cell line. 31 The MNA NBLW cell line failed to undergo a G 1 arrest in response to DNA damage ( Fig. 2B and C) . The G 1 :S ratio did not change significantly between the control (2.8 ± 0.1) and 24 hours post irradiation samples (3.3 ± 0.7). The proportion of cells in G 1 decreased from 60.6 ± 0.8% to 43.8 ± 0.8% after irradiation and the proportion of S-phase cells decreased from 21.3 ± 0.7% to 17.5 ± 2.7% and cells accumulated in G 2 increasing from 18.4 ± 0.8% to 39.0 ± 2.1% (Fig. 2B) . Six of the seven MNA cell lines NBLW, SMSKCNR, CHLA-136, CHP902R, TR14, and LS failed to G 1 arrest after irradiation. The G 1 :S ratios decreased or remained the same after irradiation (Fig. 2B and C) . The G 1 :S ratio of the MNA CHP902R cell line increased after irradiation, however this was not statistically significant (p = 0.13). The only MNA cell line that did G 1 arrest was the PER-108 cell line, which also has higher levels of p21 WAF1 and hypo RB induction after irradiation (Table 1 and Fig. 1) .
Cell cycle data from the 13 cell lines analysed in the current study was combined with existing data on NGP, IMR-32, SK-N-BE(1n), SHEP, SK-N-SH and SH-SY-5Y cell lines from 17 and 18 in Figure 2D . MNA cell lines had significantly lower increases in G 1 :S ratio after irradiation when compared with non-MNA neuroblastoma cell lines (p < 0.001).
Apoptosis after irradiation induced DNA damage. The apoptotic response to irradiation was compared in five non-MNA and eight MNA neuroblastoma cell lines including four previously studied cell lines 17, 18 (Fig. 3) . The non-MNA LAN-6, SJNB-1, GIMEN, SHSY5Y and SKNRA cell lines underwent lower levels of apoptosis measured by Hoechst staining following irradiation compared with PER-108, NBLW, CHLA-136, LS and SMSKCNR MNA cell lines. Maximal levels of apoptosis at 96 hours were 5-24% by Hoechst and 16-36% by FACs for the above non-MNA cell lines compared with 42-70% apoptosis for the above MNA cell lines (Fig. 3A-C) . The non-MNA NB69 cell line was more sensitive with maximal levels of apoptosis of 55% and 50% at 48 hours measured by FACs and Hoechst respectively and the MYCN and MDM2 amplified TR14 cell line was more resistant with maximal apoptosis being 24% by FACs and 18% by Hoechst. Levels of apoptosis were generally higher measured by FACs compared with Hoechst, but particularly so for GIMEN cells (Fig. 3A and B) . There was no cleaved caspase-3 after irradiation in GIMEN cells (Fig. 3D) compared with NB69 cells, where cleaved caspase-3 was present from 24 hours after irradiation. This confirmed the apoptosis levels measured by Hoechst and suggested FACs analysis had over-estimated apoptosis. There was no significant difference in levels of apoptosis 96 h post irradiation in MNA compared with non-MNA cell lines as determined by FACs. However, levels of apoptosis measured by Hoechst were significantly higher in MNA cell lines than non-MNA cell lines (p < 0.05). 4A) . Levels of total RB remained constant (data not shown).
Effect of induced MYCN expression in
After irradiation both Tet21N MYCNand Tet21N MYCN + cells underwent a G 1 arrest. The G 1 :S ratio in the Tet21N MYCN -cells increased significantly from 12.7 ± 1.8 in the control to 28.9 ± 4.5, after irradiation (p < 0.005). The G 1 :S ratio of the Tet21N MYCN + cells increased significantly from 7.7 ± 0.7 in the control to 20.9 ± 2.0 after irradiation (p < 0.005) (Fig. 4B) . The G 1 population was higher in Tet21N MYCN -cells under normal growth conditions: 79.5 ± 2.0% compared with 70.4 ± 1.8% in Tet21N MYCN + cells (Fig. 4B) . Growth curve assays revealed that Tet21N MYCN + cells had a faster doubling time of 78.5 ± 1.4 hours, compared with Tet21N MYCN -cells (90.4 ± 1.2 hours) (data not shown). Tet21N MYCN + cells underwent more apoptosis after irradiation than Tet21N MYCN -cells 18.8 ± 3.9 % apoptosis compared with 4 ± 1.1 % 72 hours post irradiation respectively (data not shown).
The level of Tet21N MYCN expression in the Tet21N SHEP cells were compared with the other cell lines at the mRNA and protein level (Fig. 4C and D Fold increases for p53, p21 WAF1 , Hypo RB and total RB are relative to the SCR control. Cell cycle data for the siRNA treated MNA cell lines is expressed as G 1 :S ratios. The differences in the mean G 1 :S ratio between MYCN siRNA treated and SCR controls were compared using a Mann Whitney test. siRNA experiments were carried out n = 3. were comparable to MYCN levels observed in MNA cell lines (Fig. 4D) . Surprisingly, the CHP902R cell line had no MYCN mRNA or protein expression despite being MNA. The non-MNA LAN-6, NBL-S and SJNB-1 have all been reported to have higher levels of MYCN expression compared with other non-MNA cell lines, 16, 20, 22 which was confirmed here at the RNA and protein level ( Fig. 4C and D) . Reduction of MYCN levels using siRNA and the effect on the cell cycle. MYCN knockdown using siRNA in 3 MNA p53 wt neuroblastoma cell lines: IMR-32, NBLW and NGP caused a significant G 1 arrest in all 3 cell lines (Table 2 and Fig. 5 ). Under normal growth conditions there was a significant increase in the G 1 :S ratio between the SCR and MYCN siRNA treated IMR-32 control samples (p < 0.001) (Figs. 5b, c and Table 2 ). The G 1 population increased from 51.6 ± 1.0 % to 65.5 ± 0.8 % when treated with MYCN siRNA, accompanied by a small decrease of 6.9 ± 0.7% in the S-phase (Fig. 5B and C) . MYCN knockdown in the NGP, NBLW and IMR-32 cell lines increased the levels of p21 WAF1 and hypo RB without affecting p53 protein levels ( Table 2 and Fig. 5A ). MDM2 levels also remained unchanged (data not shown). The smaller increases in p21 WAF1 and hypo RB in NBLW cells may be due to the lower levels of MYCN knockdown (Table 2) .
MYCN knockdown in the p53 mutant, MNA cell line SKNBE(2c) (Fig. 6 and Table 2 ) also induced a significant G 1 arrest (p < 0.01). MYCN siRNA treatment increased the G 1 population by 8.1 ± 0.9% compared with the SCR controls. The S-phase also decreased by 3.9 ± 0.7% (Fig. 6B and C ). There were no changes in the levels of CDK inhibitors p21 WAF1 , p27 cip/kip or hypo RB after MYCN knockdown (Fig. 6A) .
The effect of MYCN knockdown on the G 1 checkpoint in response to irradiation in MNA cell lines. MYCN knockdown in MNA cell lines did not restore a G 1 arrest in response to DNA damage. None of the p53 wt MNA cell lines showed a statistically significant increase in G 1 :S phase ratio after irradiation. The G 1 : S ratio of MYCN siRNA treated IMR-32 cells decreased from 5.0 ± 0.5 to 3.1 ± 0.3 after irradiation (Fig. 5B) . The G 1 :S ratio of the IMR-32 cells treated with SCR siRNA remained constant at 2.5 ± 0.3 and 2.6 ± 0.3 in the non-irradiated and irradiated samples respectively. The G 1 :S ratio of NGP and NBLW cells both decreased after irradiation and the cells failed to undergo a G 1 arrest regardless of MYCN knockdown (data not shown).
DIsCUssIon
Lower levels of p21 WAF1 and hypo RB induction and a failure to G 1 arrest in MNA neuroblastoma cell lines after DNA damage. MNA is significantly associated with lower levels of p21 WAF1 induction and hypo RB accumulation and a failure to G 1 arrest after DNA damage (Table 3) . It has previously been suggested that the abrogation of G 1 arrest in neuroblastoma is caused by dysfunctional p21 WAF1 unable to bind Cdk2 as immunoprecipitation revealed an absence of p21 WAF1 -cdk2 complexes in NBL-S, SJNB-1 and NB1643 cells. 16 However, the current study has shown that NBL-S and SJNB-1 cells do G 1 arrest in response to DNA damage and the failure to G 1 arrest in MNA neuroblastoma cell lines is more likely to be dependent on lower levels of p21 WAF1 induction after irradiation, as opposed to dysfunctional p21 WAF1 .
It is possible that the attenuated p21 WAF1 induction is due to MYCN repression of p21 WAF1 after irradiation. After MYCN knockdown p53 wt MNA cell lines showed increases in p21 WAF1 and hypo RB, with no change in p53 levels. This would be consistent with direct repression of p21 WAF1 transcription by MYCN similar to p21 WAF1 repression by c-MYC. 32, 33 However, conditional MYCN expression in the Tet21N cells to levels comparable with those in MNA cell lines did not affect p21 WAF1 induction or the G 1 checkpoint after irradiation. In addition the MYCN over expressing cell lines NBL-S, SJNB-1 and LAN-6 all had high p21 WAF1 induction and underwent a G 1 arrest and the MNA CHP902R cell line has low MYCN expression and low levels of p21 WAF1 induction. Finally, MYCN RNAi in 3 wt p53 MNA cell lines did not restore a G 1 arrest in response to DNA damage. Taken together this data shows lower levels of p21 WAF1 induction and a failure to G 1 arrest in response to DNA damage are not due to high MYCN expression alone.
Another factor may be cooperating with MYCN in MNA cell lines to lower p21 WAF1 levels such as H-Twist. Levels of H-Twist expression have been found to correlate strongly with MYCN expression in both tumours and cell lines. In addition to being apoptotic, H-twist expression has been reported to attenuate p53 function after irradiation, lowering levels of p21 WAF1 induction. It is possible that H-Twist is responsible for the low levels of p21 WAF1 induction and subsequent failure to G 1 arrest observed in this paper. However the anti-apoptotic effects described in 34 were not demonstrated in the panel of cell lines tested, as MNA neuroblastoma cell lines were more likely to undergo apoptosis than non-MNA cell lines 96 hours post irradiation (p < 0.05).
It is also possible that other genetic aberrations that coexist with MYCN amplification may be responsible for the failure to G 1 arrest in response to DNA damage. MNA neuroblastoma cells often have other chromosomal gains and losses that occur in neuroblastoma including allelic loss of 1p and 17q gain. 35 Alternatively it is possible that the expression of coamplified genes on the MYCN amplicon may be involved in the failure to G 1 arrest, such as DDX1, N-cym, or NAG. Little is known of the functions of genes in the amplicon (reviewed in ref. 36) . MNA cell lines are more sensitive to apoptosis after irradiation. In this study MNA neuroblastoma cell lines underwent significantly higher levels of apoptosis after DNA damage compared with non-MNA cell lines (Table 3) . MYCN may switch the p53 response to DNA damage from cell cycle arrest to apoptosis through the transcription of apoptosis mediators including PUMA and PIG3 in a similar manner to that described for c-MYC. 33 The non-MNA NB69 cell line which had lower levels of p21 WAF1 induction than other non-MNA cell lines underwent high levels of apoptosis after irradiation and is c-MYC overexpressing. 37 Interestingly, MYCN expression in the Tet21N cell line increased apoptosis after irradiation (data not shown) however the cells still underwent a G 1 arrest with high levels of p21 WAF1 after irradiation (Fig. 4) . The MYCN and MDM2 amplified cell lines TR14 and NGP underwent less apoptosis than other MNA cell lines (Table 3) , and in addition to lower levels of p21 WAF1 and hypo RB after irradiation, there was also less induction of p53, as MDM2 attenuates the function of p53. Lower levels of p53 function would prevent apoptotic pathways from being activated. 38 The MNA IMR-32 cell line also has lower levels of apoptosis compared with other MNA cell lines (Fig. 3 and Table 3 ), which is possibly because it is methylated for caspase-8. 39 MYCN siRNA alters the proportion of cells in G 1 . MYCN influences control of cell cycle progression, as reduction of MYCN expression in 4 MNA cell lines caused a significant increase of cells in G 1 compared with the SCR siRNA ( Table 2) . Cell cycle data from the SHEP Tet21N experiments supports these findings as Tet21N MYCN-cells had a higher G 1 :S ratio than Tet21N MYCN + cells under normal growth conditions, and levels of hypo RB were higher in control Tet21N MYCN -cells than Tet21N MYCN + cells, indicating that MYCN expression decreased the proportion of cells in G 1 , as previously reported. 7 Studies using protein-nucleic acids to selectively inhibit MYCN activity in neuroblastoma cell lines have also reported an increase in the G 1 population in IMR-32 cells when MYCN activity was inhibited. 40 In the current study, knockdown of MYCN in the 3 p53 MNA wt neuroblastoma cell lines increased levels of p21 WAF1 and hypo RB without an alteration in p53 levels. MYCN knockdown causes a baseline G 1 arrest, but knock down of MYCN is not sufficient to restore a further increase in G 1 arrest after DNA damage in MNA cell lines.
MYCN knockdown in the SKNBE(2c) p53 mutant cell line induced a significant G 1 arrest without accumulation of p21 WAF1 or hypo RB, indicating that although induction of p21 WAF1 after MYCN knockdown plays a role in causing a G 1 arrest in p53 wt neuroblastoma cell lines, p53 mutant cell lines can undergo a G 1 arrest independent of p53, p21 WAF1 and p27 kip1 . In the absence of p53 function, MYCN may act downstream of RB to affect the G 1 checkpoint, perhaps by a direct effect on E2F1 as has been suggested for c-MYC. 41 Knocking down MYCN or inhibiting its activity to induce growth arrest may be of benefit clinically in neuroblastomas with functional inactivation of the p53 pathway, as is sometimes found at relapse.
ConCLUsIons
This study is the first to show that MNA is significantly associated with lower levels of p21 WAF1 induction, hypo RB accumulation and a failure to G 1 arrest after DNA damage in neuroblastoma cell lines. Neuroblastoma cell lines with low levels of p21 WAF1 and hypo RB induction undergo more apoptosis than those with higher levels of p21 WAF1 and hypo RB induction. Modulating MYCN expression either by conditional expression or MYCN knockdown using siRNA in MNA cell lines did not influence the G 1 arrest in response to DNA damage. We conclude that neuroblastoma cell lines that fail to G 1 arrest have lower levels of p21 WAF1 induction and hypo RB accumulation after DNA damage; however the MYCN oncoprotein alone is not causally responsible. 
